BioCentury
ARTICLE | Clinical News

Dengvaxia tetravalent dengue vaccine regulatory update

August 1, 2016 7:00 AM UTC

Costa Rica approved Dengvaxia from Sanofi’s Sanofi Pasteur vaccines division to prevent dengue fever infection in people ages 9-45 living in endemic areas. The vaccine is approved in Mexico, Brazil, E...